What is the significance of a SHBG level of 2.4 ng/mL and what evaluation should be performed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

SHBG 2.4: Critical Evaluation Required

An SHBG level of 2.4 nmol/L is severely low and requires immediate comprehensive evaluation for underlying metabolic, endocrine, and hepatic pathology, as this value falls far below established reference ranges and indicates significant pathophysiology.

Understanding the Severity

Assuming your SHBG is reported in nmol/L (the standard unit), a value of 2.4 is critically abnormal. For context:

  • Normal reference ranges typically start around 12-15 nmol/L for younger women and 23-24 nmol/L for older women and men 1
  • The 25th percentile cutoff for low SHBG in healthy controls is approximately 51.90 nmol/L in Asian populations 2
  • Your value of 2.4 nmol/L represents less than 20% of even the lowest normal thresholds

This is not a borderline finding—this represents severe SHBG suppression that demands investigation.

Clinical Significance

Primary Concerns with SHBG This Low:

Metabolic dysfunction is the most likely driver. SHBG is normally reduced in:

  • Obesity and metabolic syndrome (most common cause) [@2,3,4,5,6@]
  • Insulin resistance and hyperinsulinemia - insulin directly suppresses hepatic SHBG production 3
  • Type 2 diabetes or prediabetes - low SHBG predicts diabetes development 1, 2

Hepatic pathology must be excluded:

  • Severe liver disease can paradoxically lower SHBG (though cirrhosis sometimes raises it) [@2,3@]
  • Fatty liver disease/NASH commonly associated with low SHBG

Androgen excess states:

  • Polycystic ovary syndrome (PCOS) - if female with irregular cycles, hirsutism 4, 2
  • Androgen-secreting tumors (though these typically present with very high testosterone)

Required Evaluation

Immediate Laboratory Assessment:

  1. Total testosterone - first-line test for hyperandrogenism [@2,5@]

    • If testosterone is twice the upper limit of normal, add DHEAS to evaluate for adrenal vs ovarian source [@2,3,5,6@]
  2. Metabolic panel:

    • Fasting glucose and insulin (calculate HOMA-IR)
    • HbA1c
    • Lipid panel (triglycerides correlate inversely with SHBG) 5
  3. Liver function tests:

    • AST, ALT, bilirubin, albumin
    • Consider hepatitis panel if risk factors present
  4. Thyroid function (TSH, free T4):

    • Hypothyroidism lowers SHBG; hyperthyroidism raises it 6, 7
    • Normal thyroid function with low SHBG helps exclude thyroid causes

Clinical Assessment Details:

For women:

  • Menstrual cycle pattern (oligomenorrhea suggests PCOS)
  • Hirsutism assessment (modified Ferriman-Gallwey score)
  • Acne, androgenic alopecia
  • Body mass index and waist-to-hip ratio 2

For men:

  • Signs of hypogonadism vs androgen excess
  • Erectile function, libido changes
  • Body composition changes

For all patients:

  • Weight history and distribution
  • Family history of diabetes, metabolic syndrome
  • Medication review (especially estrogens, anticonvulsants, thyroid medications) [@3,6@]
  • Alcohol consumption

Interpretation Caveats

Critical point: When SHBG is this low, total testosterone measurements become unreliable for assessing true androgen status [4, @2,4@].

  • Low SHBG increases free (bioavailable) testosterone even when total testosterone appears normal
  • You may have biochemical hyperandrogenism despite "normal" total testosterone [@4,6@]
  • Calculate free androgen index (FAI = [Total testosterone/SHBG] × 100) or measure free testosterone directly (preferably by equilibrium dialysis or calculated using validated formulas)

Clinical Implications

Cardiovascular and Metabolic Risk:

Low SHBG independently predicts:

  • Increased cardiovascular disease risk 3, 5
  • Higher stroke risk in women (HR 1.61-1.88 for lowest vs highest quintile) 8
  • Development of type 2 diabetes 1, 2
  • Overall mortality in postmenopausal women 3

Your SHBG of 2.4 places you at substantially elevated risk for these outcomes and warrants aggressive risk factor modification.

Management Priorities:

  1. Address insulin resistance (if present):

    • Weight loss if overweight (most effective intervention)
    • Metformin consideration if prediabetic/diabetic or PCOS
    • Lifestyle modification (diet, exercise)
  2. Treat underlying endocrine disorders:

    • PCOS management if diagnosed
    • Thyroid replacement if hypothyroid
    • Address any identified tumors
  3. Cardiovascular risk reduction:

    • Aggressive management of hypertension, dyslipidemia
    • Smoking cessation
    • Consider low-dose aspirin if appropriate

Common Pitfalls to Avoid

  • Don't dismiss normal testosterone levels when SHBG is this low—calculate free testosterone or FAI [@4,6@]
  • Don't attribute low SHBG solely to obesity without excluding other pathology (tumors, liver disease, thyroid dysfunction)
  • Don't overlook medication effects (estrogens raise SHBG; some anticonvulsants affect it) [@3,6@]
  • Don't delay evaluation of such a severely abnormal value—this requires prompt workup

The combination of severely low SHBG with clinical hyperandrogenism symptoms demands investigation even when total testosterone appears normal, as the free androgen burden may be significantly elevated [@2,4,5,6@].

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.